DexCom Inc (DXCM) — Cash Flow Reinvestment Rate
DexCom Inc (DXCM) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting $510.30 Million (capex $101.90 Million plus investments $408.40 Million) from operating cash flow of $294.00 Million. Explore DXCM capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DexCom Inc Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for DexCom Inc across 13 annual periods. Also explore DexCom Inc (DXCM) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for DexCom Inc (2013–2025)
Year-by-year capital reinvestment analysis for DexCom Inc. For live market cap and broader valuation context, see DXCM market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $1.26 Billion | $1.44 Billion | $363.50 Million | ▲ +53.1% |
| 2024 | 0.57x | $566.30 Million | $989.50 Million | $358.80 Million | ▼ -68.3% |
| 2023 | 1.81x | $1.35 Billion | $748.50 Million | $236.60 Million | ▲ +140.4% |
| 2022 | 0.75x | $503.30 Million | $669.50 Million | $364.80 Million | ▼ -42.9% |
| 2021 | 1.32x | $582.40 Million | $442.50 Million | $389.20 Million | ▼ -37.8% |
| 2020 | 2.12x | $1.01 Billion | $475.60 Million | $199.00 Million | ▼ -34.4% |
| 2019 | 3.23x | $1.02 Billion | $314.50 Million | $180.00 Million | ▲ +209.5% |
| 2018 | 1.04x | $128.50 Million | $123.20 Million | $67.10 Million | ▼ -33.5% |
| 2017 | 1.57x | $144.40 Million | $92.00 Million | $66.00 Million | ▲ +57.0% |
| 2016 | 1.00x | $56.20 Million | $56.20 Million | $55.70 Million | ▼ -3.9% |
| 2015 | 1.04x | $51.00 Million | $49.00 Million | $33.30 Million | ▲ +46.2% |
| 2014 | 0.71x | $16.80 Million | $23.60 Million | $16.20 Million | ▼ -95.3% |
| 2013 | 15.29x | $36.70 Million | $2.40 Million | $7.90 Million | — |